Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 2 | Arthritis Research & Therapy

Figure 2

From: Tumor necrosis factor inhibitor therapy but not standard therapy is associated with resolution of erosion in the sacroiliac joints of patients with axial spondyloarthritis

Figure 2

Two-year change in mean Sacroiliac Joint Structural Scores for fat metaplasia and erosion in patients with axial spondyloarthritis. Cumulative probability plots illustrating 2-year change in mean Spondyloarthritis Research Consortium of Canada magnetic resonance imaging Sacroiliac Joint Structural Scores for (A) fat metaplasia and (B) erosion in patients with axial spondyloarthritis on standard therapy (nonsteroidal anti-inflammatory drug and/or physiotherapy, n = 68) and tumor necrosis factor alpha (TNFα) inhibitor (n = 79) therapy. Tx, therapy.

Back to article page